Introduction
Conjunctival tumors are one of the most frequent tumors of the eye and adnexa. They comprise a large variety of conditions, from benign lesions such as papilloma to malignant lesions such as epidermoid carcinoma or melanoma which may threaten visual function and patient´s life if not diagnosed early. Although conjunctival tumors may arise from any type of the conjunctival cells, epithelial and melanocytic are the most frequent origins. Epithelial tumors account for a third to half of all tumors, with a higher prevalence in countries with larger actinic exposure. Aproximately 40% of the tumors have an epithelial origin and 64.5 % of them were pre-cancerous lesions (Saornil et al, 2009) . The clinical differentiation between pre-cancerous benign and malign lesions is difficult, requiring a biopsy for a definitive diagnosis.
Squamous neoplasia of the conjunctiva /cornea is a rare malignancy of conjunctival limbal stem cells, and the management of this malignancy may affect the ultimate outcome. The clinical distinction of squamous conjunctival neoplasia from other amelanocytic conjunctival tumors is based on certain clinical features of the tumor, and its correct management requires an understanding of normal anatomy and histology of the cornea and conjunctiva, as well as knowledge of the principles of tumor management.
Conjunctiva is a thin and flexible mucous membrane that extends from the internal surface of the eyelids to the fornix and anterior ocular surface up to the corneoscleral limbus. Histologically, conjunctiva is similar to other mucous membranes and comprises a non-keratinized stratified epithelium having two or more layers over the stroma formed by fibrovascular connective tissue containing vessels, nervous and lymphatic tissue. Basal layer of epithelium comprises melanocytes which produces melanine and inject it in the surrounding cells. Throughout the length of epithelium we can observe cup-shaped cells in charge of producing the mucoid component of the lacrimal film. These cells are called goblet cells.
Definition of Ocular Surface Squamous Neoplasias (OSSN)
Squamous cell neoplasia may occur as a localized lesion confined to the surface epithelium (conjunctival intraepithelial neoplasia) or as a more invasive squamous cell carcinoma that has broken through the basement membrane and invaded the underlying stroma .
Currently, the accepted term for the localized variety is conjunctival intraepithelial neoplasia (CIN). However, other authors prefer the terms dysplasia (mild, moderate, or severe) and carcinoma-in-situ. Where there are no longer normal surface cells then the process may be termed carcinoma-in-situ. Those cases where the cornea is invaded by the process are usually called conjunctiva-cornea intraepithelial neoplasia (CCIN). Squamous neoplasia constitutes the most frequent primary malignancy of the ocular surface.
Conjuntival Intraepithelial Neoplasia (CIN)
CIN is confined to the epithelium by definition. The term CIN was suggested in 1978, according with the general pathologic classification of intraepithelial tumors developed for cervical intraepithelial neoplasia (Pizzarello & Jakobiec, 1978) . CIN includes previous terms referred to this epithelial neoplasia such as: Bowen´s disease, Bowenoid epithelioma, intraepithelial epithelioma, intraepithelioma, dysplasia and carcinoma in situ (CIS).
Subjective symptoms referred by the patients include: foreign body sensation, redness, irritation, and a growth on the ocular surface (Giaconi & Karp, 2003) .
Clinically, CIN appears as a fleshy, sessile or minimally elevated lesion usually at limbus in the interpalpebral fissure and less commonly in the forniceal or tarsal conjunctiva . The limbal lesion may extend for a variable distance into the epithelium of the adjacent cornea. A white plaque (leukoplakia) may occur on the surface of the lesion due to secondary hyperkeratosis. www.intechopen.com
Squamous Cell Carcinoma (SCC)
Squamous cell carcinoma is characterized by an extension of abnormal epithelial cells through the basement membrane to gain access to the conjunctival stroma . Clinically, invasive squamous cell carcinoma is similar to CIN; however, it may be larger and more elevated than CIN. Even though the cells of invasive squamous cell carcinoma gain access to the blood vessels and lymphatic channels, regional and distant metastases are both rather uncommon. Clinically it is very difficult to distinguish between CIN and SCC (Erie et al, 1986) . In many occasions it is necessary to perform a biopsy.
Incidence
OSSN accounts for only 5% of all ocular malignancies (Lee & Hirts, 1995) . CIN is the most common conjunctival malignancy (Grossniklaus et al, 1987) . CIN occurred more commonly in pale-skinned groups than in more pigmented people, with an increased incidence in males (75%) vs females (25%), and a mean age of 60 years (Grossniklaus et al, 1987) . OSSN associated with human immunodeficiency virus (HIV) is seen at younger ages (average 35 years), usually not in a bulbar location, and is more aggressive from a clinical point of view. Its incidence can vary from 0.13 to 1.9/100.000 inhabitants (Lee & Hirts, 1995) , (Giaconi & Karpp, 2003) , (Saornil et al, 2009) . OSSN incidence varies geographically, increasing with closer distance to the equator. For example, Uganda has 1.2 cases/100.000 persons/year compared to the United Kingdom with less than 0.02 cases/100.000 persons/year. This might suggest a role of ultraviolet light exposure in the etiology of these tumors. US data indicate an incidence of 0.03/100.000 people/year, with a 6-fold increase in association with HIV infection (Sun et al, 1997) , (Verma et al, 2008) . The lesions are more common in males and elderly, with the majority occurring at the limbus. In Africa the incidence is changing. The tumor is more common, aggressive, more frequent in young persons, especially women (Ateenyi-Agaba, 1995) . This is relationed with the coexistence of pandemic AIDS and exposition to the human papillomavirus (HPV) and ultraviolet radiations. Africa has the highest prevalence of HPV infection in the world (with more than 25 % of women from 15 to 74 years affected), followed by South America (14.3%), Asia (8.7%) and Europe (5.2%) (Clifford, 2005) . A study in the Kampala Cancer Registry in Uganda showed an increase from 6 cases of OSSN/1.000.000 persons per year between 1970 and 1988 to 35 cases/1.000.000 persons per year in 1992 (Ateenyi-Agaba, 1995) . In Australia, a study found that 78.5% of affected people were male with a mean age of 60 years (Lee & Hirst, 1997) . Similarly, another study in United Kingdom showed that the 77% were male, being 69% of them older than 60 years (McKelvie et al, 2002) . Nevertheless, a study in Zimbabwe found that a 70% of patients were young women with a mean age of 35 years (Pola et al, 2003) , while in South Africa mean age was 37 years (Mahomed & Chetty, 2002) . A study in Tanzania showed that the 45.8% of 168 conjunctival biopsies were OSSN (Poole, 1999) .
Etiologic factors for CIN
To date, CIN etiology remains unclear. The most probably explanation may be multifactorial causes. There are many known factors which may contribute to the development of these neoplasias.
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The first one is the age, with an average of 60 years ( Lee & Hirst, 1995 ) . However, it ranges from 4 to 90 years. The second factor attributed is the UV light exposure (Lee et al, 1994 ). This justify a higher prevalence of CIN in the ecuatorial areas, as we have previously commented. The exposition to the petroleum products, heavy cigarrete smoking, light hair and ocular pigmentation have also been associated (Napora et al, 1990 ).
Younger patients affected by Xeroderma pigmentosum (Herle et al, 1991) and HIV may show a higher incidence (Karp et al, 1996) . The majority of CIN cases reported in Africa are HIV-positive: 71% in Uganda, 86% in Malawi (Waddell, et al 1996) , 70.6% in South Africa (Mahomed & Chetty 2002) and 92.3% in Zimbabwe (Porges & Groisman 2003) . On the other hand, the prevalence of CIN in a HIV-positive population in Kenya was 7.8% (Chisi et al, 2006) . These findings suggest that CIN is a marker for HIV infection. OSSN in HIV/AIDS patients presents at a younger age (35-40 years old) than in HIV-negative patients (Timm et al, 2004) . Additionally, malignancy seems to be more aggressive in HIV/AIDS patients (Kaimbo 1998) . It is unclear whether immunosuppression or HIV itself plays a role in this pathogenesis. Although it has been speculated about the role of HIV in conjunctival squamous cell carcinoma in immunosuppression and activation of oncogenic viruses such as HPV in the conjunctiva, thus far only oral and anogenital HPV has been shown to occur more frequently in HIV-positive patients (Verma et al, 2008) . Immunosuppression itself may contribute to the carcinogenesis. Several studies have also demonstrated an association between immunosupression secondary to HIV infection and increased risk of cervical intraepithelial neoplasia (Palefsky, 1991) .
The role of HPV remains also unclear in the etiology of CIN. It has been proved the causal relationship between HPV type 16 and 18 and uterine cervical carcinoma (Scott el al, 2002) , (Giaconi & Karp, 2003) , (Verma et al, 2008) . However, multiple studies worldwide have failed to document an unequivocal association of HPV with conjunctival squamous cell carcinoma (Tuppurainen, 1992) , (Eng et al, 2002) . A small study of CIN has demonstrated mRNA from the E6 region of HPV, which signals actively transcribed virus (Scott et al 2002) . Furthermore, this study in United States demonstrated the lack of such mRNA from normal conjunctivas, whereas African case series have revealed a high prevalence of HPV DNA in clinically normal conjunctivas for HPV 6 and 11, but not HPV 16 and 18 were found (Verma et al, 2008) . In controversy HPV types 16 and 18 may be detected in CIN, in non neoplasic lesions and in apparently healthy conjunctiva (Karcioglu & Issa, 1997) . Another study in Thailand concluded that solar elastosis is more frequently founded in OSSN cases that in controls, and HPV DNA was not found in any of the specimens (Tulvatana et al, 2003) . HPV 5 and 8 were the most common in nearly half of OSSN in a series recently reported in Uganda (Ateenyi-Agaba, et al 2010). The frequency was the same in infected VIH than in non infected VIH. HPV 5 is not reported in caucasian CIN. HPV 16 and 18 may considerer as disease of sexual transmission whereas HPV 5 may appear by other possible vias. It has been shown in cervical cancer that the high risk variants HPV 16 and HPV 18 lead to carcinogenesis by inactivating tumor suppressor gene products p53 and Rb in the host with the viral oncoproteins E6 and E7, respectively (Verma et al, 2008) . Furthermore, integration of viral sequences into the host genome leads to the constitutive expression of E6/E7 in transformed cervical cells. HPV 5 show highest downregulation of basal interleukin-8 secretion in primary human keratinocytes. This may weaken the response to UV-induced damage and consecutively mutations. Given the conflicting association studies, it appears that UV-B radiation plays a much greater role than HPV in the etiology of CIN (Verma et al, 2008) .
Clinical presentation of CIN
The clinical presentation of CIN may be variable. There are many different pictures on the ocular surface that constitute a CIN. The subjective symptoms may be also variable in intensivity. Appart from the presence of a growth or mass in their ocular suface, patients may complain no symptoms. Size, color and growth may be variable in each case. The presence of a red eye make, sometimes, that the patient was treated as a conjunctivitis. Foreing body sensation, redness, or irritation may be referred many times. CIN is characterized by a slowly progressive course with low malignant potential. In general, two forms of CIN have been described: nodular (or well localized) and diffuse. The diffuse type is less common and very difficult to diagnose in early stages. This situation may be similar to a chronic conjunctivitis and its surgical treatment may result complicated because clinical borders of the lesion may be indistinguishable (Lee & Hirst, 1995) , (Giaconi & Karp, 2003) .
The typical location of this slow-growing lesion is the interpalpebral limbus, but it may also arise in the forniceal and palpebral conjunctiva. Limbal lesions may spread onto the cornea. The abnormal corneal epithelium has a frosted appearance with fringed borders and usually demonstrates diffuse punctate staining. Flat or elevated, the lesion may appear relatively translucent, gelatinous, or pearly white. Secondary hyperkeratosis over the surface of the lesion may give rise to a white plaque-like appearance clinically named leukoplakia. Often, there are surrounding corkscrew-like vascular tufts. Pigmentation may be seen and the lesion may be clinically misdiagnosed as melanoma .
The percentages of CIN that develops into SCC have not been reported in the literature. In cases of SCC the tumor may reach to eye globe, the orbit and cranial extension, with vision loss due to a enucleation or exenteration (Lopez-Garcia et al, 2000) . Up to 4% rates of metastasis to cervical lymph nodes have been reported, while metastases to distance are less common (Bhattacharyya et al, 1997) . There is not a particular simptomatology for every macroscopic form of CIN. Some of the characteristic forms of presentation of precancerous and malignant lesions are described:
Precancerous lesions: Actinic keratosis and conjunctival keratotic plaque
Both lesions, impossible to differentitate clinically, consist in a white plaque on the limbal or bulbar conjunctiva, in the exposed interpalpebral conjunctiva. They have a low grade of proliferation and very few possibilities to convert into CIN or SCC. Definitive diagnosis consisted in the histological study (Mauriello el al 1996) , .
Leucoplakic lesions
Leucoplakia (white plaque) consist in a conjuctival lesion, generally at the limbus, which may be round or irregular. A process of keratosis is involved . These lesion may also extend onto the cornea. Likewise, leukoplakic lesions may appear www.intechopen.com onto a very diffuse CIN (Huerva et al, 2006) . Extensive leukoplakia should raise suspiction of invasive SCC . 
Papillomatous lesions
CIN may developed simulating a sessile papilloma. The lesion consist in a fleshy red appearance owing numerous fine vascular channels that ramify throughtout the stroma beneath the epithelial surface of the lesion . The presence of displasic epithelial cells helps to the differential diagnosis between papilloma and CIN. In rare occasions papillomas may developed into a CIN. Fig. 3 . CIN with papillomatous appearance at the exposed interpalpebral fissure affecting the limbus.
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Fleshly lesions
Clinically, CIN appears as a fleshy, sessile, or minimally elevated lesion usually at the limbus in the interpalpebral fissure and less commonly in the forniceal or palpebral conjunctiva. The size of extension may be variable in each case. The presence of redness may simulate an inflammation. Extensive cases consist in a red gelatinous mass with vascular dilatations that may invade superior and nasal bulbar conjunctiva, including the caruncula, inferior conjuctiva and fornix invading tarsal conjunctiva and even corneal extension. Plaques of leukoplakia may also be present. (Erie et al, 1986) , , (Huerva et al, 2006) . 
Corneal invasion (Conjunctiva-Cornea Intraepithelial Neoplasia) (CCIN)
This condition is called when the fleshy or papillomatous CIN lesions invading the superficial cornea. The lesions are well documented at the limbus occuping different degrees. Generally, in the extensive cases the cornea may be invaded (Huerva et al, 2006) . The form of invasion may be variable: nodular, frothy vascular irregular extension and pedunculated and may simulate other conjunctival lesions as a pterigium or pannus . www.intechopen.com
Squamous cell carcinoma
Clinical presentation of invasive SCC is the same that the CIN. As the CIN, it is frequently observed at the interpalpebral region. Definitive diagnosis is only histopathologic (Shileds & Shields, 2008) .
There are some different histological types with very aggressive potential effect. Mucoepidermoid or adenoid SSC has an epidermal component and variable quantities of mucin. It often presents with inflammatory signs ( Mauriello et al, 1997) . Spindle cell SCC is composed by pleomorphic spindle cells. Both are very aggressive with high potential of ocular invasion and distant metastases . 
Diferential diagnosis
Clinical differentiation between CIN and other limbal lesions is based on characteristic clinical features (Erie et at, 1986) . However, it is generally admitted that the grade of dysplasia cannot be consistently determined on clinical inspection alone (Lee & Hirts, 1995) . The main differential diagnoses for localized CIN include pinguecula, pterygium and squamous papilloma. The differential diagnosis of conjuctival amelanotic tumors includes CIN, invasive SCC, malignant melanoma and a variety of benign described entities, which include squamous papilloma, solar elastosis and epithelial hyperplasia, keratosis or reactive www.intechopen.com atypia. Conjunctival pseudoepitheliomatous hyperplasia, keratoacantoma, and conjunctival hereditary benign intraepithelial dyskeratosis may be also considered in CIN diferential diagnosis . In these cases the hyperkeratosis and inflammatory cells are present in the histologic samples. Solar elastosis is a pathognomonic sign in the pathological diagnosis of degenerative diseases of the conjunctiva such as pingueculae and pterygium. In a study, the clinical diagnosis of OSSN may be accurate in 89.5% of the cases (Tulwatana et al, 2003) . Solar elastosis was found in 53.3% of OSSN cases compared to 3.3% of matched controls. Solar elastosis has also been identified as a risk factor for OSSN (Tulwatana et al, 2003) . On this basis, the clinical diagnosis alone cannot distinguish benign conjuntival limbal tumors from OSSN or reliably exclude, albeit an uncommon diagnosis, amelanotic malignant melanoma. The difficulty in distinguishing clinically between pterygium and CIN was illustrated in a histopathological review of 533 cases of pterygium, in which 9.8% were shown to have evidence of dysplasia (Hirst et al, 2009 ). The capacity of a clinician to distinguish between grades of CIN, or between CIN and invasive SCC, is also limited (Rudkin et al, 2011) . Clinical diagnosis of CIN may be increased by the use of exfoliation or impression cytology. However, histopathology of the excised tumor is the only reliable diagnostic method and it is generally accepted to be the most appropriate approach to lesions presumed to be CIN. The main hazard of clinical misdiagnosis of an excised benign limbal lesion is exposing the patient to unnecessary surgery. For an experienced ocular oncologist, the misdiagnosis of localized limbal OSSN occurs in 10.5% of cases (Rudkin et al, 2011) . 
Impression cytology in diagnosis of CIN
The management of ocular surface neoplasia depends on the ability to distinguish between benign, preinvasive, and invasive lesions. However, follow-up of suspicious lesions by repeated biopsies may cause complications such as scarring, lid deformity, limbal deficiency, and patient discomfort.
As it has been described, the clinical appearance of the lesion may be suggestive of CIN. However, a tissue biopsy is necessary to confirm the diagnosis. Because many patients with www.intechopen.com primary or recurrent CIN may be treated with topical chemotherapy without surgical excision of the lesion, impression cytology has been used to confirm the diagnosis without performing histological evaluation of the excisional biopsy. Impression cytology is a simple technique for removing one to three superficial layers of the epithelium by applying collecting devices, either cellulose acetate filter papers or Biopore membrane device. Rates of positivity between 77 and 80% have been reported (Nolan et al, 1994) , (Tole et al, 2001 ). The disadvantage is that the superficial nature of the sample, which sometimes only contains keratinized cells, may be falsely negative. Cytological assessment does not provide enough information regarding the deepest structure of the lesion, in particular, evidence of invasion. Abundance of surface keratin may make sampling inaccurate. Another limitation is that impression cytology may not distinguish in situ from minimally invasive disease, because only superficial cells are collected in the method. However, high-grade dysplasia in OSSN cytology findings have a high correlation with histology findings, and the presence of abundance dysplastic cells in cytology suggest preinvasive or invasive disease in subsequent histology (Tananuvat et al, 2008) . Although impression cytology have a high sensitivity for the diagnosis of ocular surface squamous neoplasia, including CIN, there are still cases in which impression cytology yields false negative results. The keratotic surface of the lesion or the presence of dysplastic cells deep within the epithelium are the reason for these false negative results. Repeated consecutive applications of the collecting filter paper to the surface of CIN by approaching the deeper epithelium may result in higher sensitivity of the technique to confirm the diagnosis (Kheirkhah et al, 2011) . For the diagnosis of CIN, the second and third applications of impression citology may be significantly more sensitive than the first application. Consecutive repeated applications of the filter paper resulted in a significant higher sensitivity due to access to deeper epithelium. Keratinizing CIN lesions may result in a false negative impression cytology test due to the small number of cells present in the sample. It seems that keratinization leads to more false negative results at first application and repeated sampling in this population of CIN cases is more likely to result in subsequent positive due to the progressive elimination of the keratotic material. In conclusion, repeated consecutive applications of impression citology will lead to a more significant sensitivity for diagnosis in eyes with CIN, thereby obviating the need for excisional biopsy. An additional advantage of impression cytology is the preservation of limbal stem cells, which are located in the basal layer of the limbal epithelium and are responsible for renewal of corneal epithelium throughout life. In most cases of OSSN, the lesions affect predominantly the limbus and have a tendency to recur. Moreover, the technique may be used in the follow-up of patients after treatment to determine the recurrence of the disease, as well as the effects of treatment such as topical chemotherapy.
Histopathological findings
The definitive term of CIN or SCC corresponds to the histologic study. When the abnormal conjunctival epithelial cellular proliferation involves only partially the epithelium thickness is classified as mild CIN, a condition also called mild or moderate dysplasia. When it affects full thickness epithelium it is called severe CIN, a condition also called severe dysplasia. In these cases there may be an intact surface layer of cells. Where there are no longer normal surface cells then the process is termed carcinoma-in-situ. Histopathologically, mild CIN (dysplasia) is characterized by a partial thickness replacement of the surface epithelium by abnormal epithelial cells which lack of normal maturation. Severe CIN (severe dysplasia) is characterized by a nearly full-thickness replacement of the epithelium by similar cells. Carcinoma-in-situ represents full thickness replacement by abnormal epithelial cells . Squamous cell carcinoma is an extension of abnormal epithelial cells through the basement membrane to gain access to the conjunctival stroma and have grown in sheets or cords into the stromal tissue. A rare variant of squamous cell carcinoma of the conjunctiva is the mucoepidermoid carcinoma wich presents abundant mucous-secretory cells within cysts. Another rare variety is the spindle cell variant of squamous cell carcinoma that is likewise aggressive. Histopathologically, invasive squamous cell carcinoma is characterized by malignant squamous cell that have violated the basement membrane www.intechopen.com . According to the definition, CIN may be classified in four stages (Kheirkhah et al, 2011) : 
Human Papilloma Virus (HPV) detection
As it has been described in the chapter of etiologic factors, the presence of HPV in cases of CIN remains controversial. DNA of HPV may be detectable by in situ hybridization. HPV types 16 and 18, commonly detectable, in uterine cervix may also be detectable in CIN. However, in non neoplasic lesions and in apparently healthy conjunctiva it may also be detectable ( Karcioglu & Issa, 1997) . In African case series there is a high prevalence of DNA HPV 6 and 11, but not HPV 16 and 18 (Verma et al, 2008) . On the other hand, in a series reported recently in Uganda, HPV 5 and 8 were the most common in nearly half of OSSN (Ateenyi-Agaba, et al, 2010) . We have detected the presence of DNA HPV type 11. It is possible that different HPV associated to other risk factors may contribute to the development of CIN.
The presence of DNA HPV is not strictly necessary in the diagnosis of CIN. However, when it is possible its determination may clarify the role of these different types of virus in the development of CIN. MX Distant metastasis cannot be assessed
Staging for conjunctival intraepithelial neoplasia

M0 No distant metastasis
M1 Distant metastasis
According to this classification with the difference of clinical appearance, the cases of CIN may be: Tis, T1 or T2, N0 and M0.
Treatment
The management of CIN or SCC of the conjunctiva varies with the extent or recurrence of the lesion.
Surgical treatment
While the extent of the lesion determines the management of lesions in the limbal area involves alcohol epitheliectomy for the corneal component and partial lamellar scleroconjunctivectomy, with wide margins (4-5 mm) for the conjunctival component followed by freeze-thaw cryotherapy to the remaining adjacent bulbar conjunctiva (The no touch technique) . In some cases, microscopically controlled excision (Mohs surgery) may be performed at the time of surgery to ensure tumor free margins (Buus et al, 1994) . Those tumors in the forniceal region can be managed by wide local resection and cryotherapy. Following surgical excision, large conjunctival defects may be successfully reconstructed with transpositional conjunctival flaps, free conjunctival grafts, oral mucosal grafts, and amniotic membrane grafts (Gündüz et al, 2006) . In all cases, the full conjunctival component along with the underlying Tenon's fascia should be excised using the "no touch technique". A thin lamella of underlying sclera should be removed, in the limbal región, when the tumor is adherent to the globe. Intraoperative mitomycine-C (MMC) application has also been combined with excision of ocular surface neoplasia to prevent postoperative recurrences (Siganos et al, 2002) . However, studies show a 53% recurrence rate in pathologic studies which revealed involved margins and a 5% recurrence rate when clear margins are confirmed (Erie et al, 1986) . In extensive lesions, surgical excision is difficult, and additional procedures have been employed. Extensive resections in very extensive CIN may produce a limbal stem deficiency (Huerva et al, 2006) . Adjuvant radiation has the potential complications of cataracts, scleral necrosis, corneal rupture, scarring of the cornea and conjunctiva, moderate to severe conjunctivitis, and loss of eyelashes (Giaconi & Karp, 2003) . For those patients with extensive tumors or those tumors that are recurrent, treatment with topical mitomycin C, 5-fluorouracil, or interferon alfa 2b have been employed.
Topical chemoteraphy
Topical chemotherapy has a number of advantages over surgical approach. It enables to treat the entire ocular surface and is not dependent upon surgical margins. Primary treatment with a chemotherapeutic agent avoids potential complications of surgery, which can include scarring of the conjunctiva and cornea, limbal stem cell failure and incomplete excision of the lesion. Topical chemotherapics may be preferred over surgery by some patients, and when the patient refuse surgery, topical chemotherapics have been successfully used as primary treatment.
Topical mitomycin C (MMC)
For tumors with extensive involvement, where surgical removal bears significant risks for postoperative problems, topical MMC should have been considered for a long time. Topical MMC 0.02% or 0.04% 4 times daily in 7 to 14-day for two cycles have been successfully employed for preoperative chemoreduction and to manage recurrent and residual tumors following surgical resection (Shields et al, 2002) , (Frucht-Pery et al, 2002) , (Shields et al,2005) . MMC had been effectively used to treat primary CIN, with reported success rates between 85% (Wilson et al, 1997) and 100% (Frucht-Pery & Rozenmam, 1994) , (Ramos-Lopez et al, 2004) . Another large study has shown topical MMC to be an efficient treatment of most, but not all cases, of CIN. Tumor regrowth occurred in approximately 17% of cases (Frucht-Pery et al,1997) . To avoid possible complications, the lacrimal punctal occlusion is mandatory during topical treatment. Chemoreduction with MMC cycles reduced the tumor size, especially in the surrounding thinner portions, and allowed for a subsequent limited surgical excision in all cases (Shields et al, 2005) . Possible complications with topical MMC include superficial punctate epitheliopathy , conjunctival hyperemia, pain, allergy, corneal-scleral, melting disturbance of tear film stability, goblet cell loss, squamous metaplasia and limbal stem cells depletion (Frucht-Pery & Rozenmam, 1994) , (Wilson et al, 1997) , (Dogru et al, 2003) , (Dudney & Malecha, 2004) , (Khong & Muecke, 2006) . Edema and endothelial apoptosis have been observed in experimental models (Chang, 2004) . MMC toxicity seems to be dose dependent, occurring with the repetition of treatment cycles. Chemoreduction with topical MMC, followed by interferon alfa 2b (1 million IU/mL) 4 times daily, is an effective treatment in extensive CIN cases where surgical resection with safety margins is infeasible and corneal extension resection and the repetitive cycles of MMC adjunctive could cause a depletion of limbal stem cells and other commented side effects on the ocular surface (Huerva et al, 2006) . In a follow-up of 18 months, topical Cyclosporine A (0,05%) combined with topical low dose of MMC (0,01%) four times a day for 12 weeks after positive margins following surgical excision showed no recurrence of the tumor (Tunc & Erbilen, 2006) . In these cases Cyclosporine A has been employed by the antineovascular effect on the ocular surface.
5-Fluoracil (5-FU)
Other treatment options in the management of CIN include 5-fluorouracil (5-FU). However, compared with MCC, the experience with this alternative treatment is limited. Topical 1% 5-FU drops used 4 times daily for 2 to 4 days for each cycle and repeated at 30 to 45 day intervals have been reported. Following initial treatment, 4 patients were disease-free with a mean follow-up of 18.5 months. Of the 3 patients with tumor recurrence, 2 remained tumor-free following additional topical 5-FU treatment and 1 patient had a persistent tumor despite additional treatment with 5-FU and became tumorfree following treatment with topical MMC (Yeatts et al, 2000) . No adverse reactions to pulsed treatment were reported. Another study using topical 1% 5-FU drops 4 times daily for 4 weeks in 8 eyes with recurrent, incompletely excised, and untreated conjunctival OSSN showed complete clinical regression at 3 months in all cases. OSSN recurred in 1 patient at 6 months but this was successfully treated with another course of 5-FU (Midena et al, 2000) . Transient toxic keratoconjunctivitis that was noticeable with this treatment. Short-term complications include lid toxicity in 52% of patients, keratopathy in 11% and epiphora in 5% (Rudkin et al, 2010) .
Interferon (INF) alpha 2b
Topical MMC and 5-fluorouracil have been used to reduce recurrence rates when used as an adjunct to surgical escisión and as a primary treatment; however, their use can be associated with marked ocular surface toxicity. Topical (1.000.000 IU/ ml/ four times a day) or subconjuctival INF alfa 2b (3 million IU/ml/ weekly) have been employed to treat CIN. In general, topical INF alpha-2b is well tolerated. Subconjunctival administration presents more side effects as flu-like symptoms (fatigue, fever, myalgias, malaise) and mild liver disturbances (Huerva & Mangues, 2008) . Local conjunctival injection and follicular conjunctivitis are the most frequently reported side effects (Schechter et al, 2002) after topical administration. Redness and increase of CIN volume without ocular discomfort have been reported in a case (Huerva el al, 2007) . Fine, diffuse, clear epithelial microcysts in the cornea after instillation of topical interferon a-2b have recently documented in other case (Aldave & Nguyen, 2007) .
Topical INF alpha 2-b, sometimes combined with subconjunctival INF alpha 2-b, seems to be effective as primary treatment for CIN, in recurrent cases, and also in retreatment after recurrence when INF has been used previously for a short period of time (Huerva & Mangues, 2008) . Approximately, 9% of CIN treated with subconjunctival and/or topical INF alpha 2b showed recurrences, and 33 % of them were successfully retreated with topical IFN alpha 2b (Huerva & Magues, 2008) . Another one (16,6%) achieved complete remission after intraperioperative MMC (Hawkins et al, 1999) . For INF alpha 2b topical treatment, the average time to complete tumor response is 11 weeks (range 2-59). For INF alpha 2b
www.intechopen.com subconjunctival and topical treatment, the average time to complete tumor response is 5.5 weeks (range 2-12), (Huerva & Mangues, 2008) . Previous studies found the same observation (Karp et al, 2001 ). The time to clinical resolution using topical INF alpha 2-b was longer (11.6 weeks) that the combined intralesional and topical interferon (4.5 weeks), but that INF alpha 2b treatment involved fewer side effects. In general, it seems that the disadvantage with topical treatment is the long duration. We must emphasize the importance of long term follow-up for CIN patients because recurrences can occur anywhere from 33 days to 11.5 years (Tabin et al, 1997) , although most recurrent CIN occurs within 2 years of initial excision (Schechter et al, 2005) .
Many surgeons add adjunctive topical therapy to their surgical regimens for larger lesions (Stone el al, 2005) . However, all sizes of lesions could be treated with topical INF alpha as the primary treatment because it is an effective, non-invasive treatment alternative to surgery that increases quality of life with low costs (Huerva et al, 2006) , (Huerva et al, 2007) , ). Actually, no clear consensus on the best way to manage the disorder has been established, because long-term, well designed studies are still needed. However, two recent studies have addressed the above questions and confirmed the effectiveness of this topical therapy for CIN. The first study (Schechter, et al, 2008) demonstrated total resolution of the tumor in 96.4% of cases treated with INF alfa 2b with a mean follow-up of 42.4 months. The second study (Sturges et al, 2008) demonstrated that topical treatment with INF and surgical excision have the same effectiveness as primary treatment for CIN for a mean follow-up of 35.6 months. The authors concluded that topical IFN alfa-2b and aggressive surgical excision can be considered equally effective as first choice for treating CIN. Topical INF alfa-2b has some advantages over conventional excision, including the reduction of risk to loose limbar stem cells secondary to surgical trauma and, thus, compromising the integrity of the ocular surface. This therapeutic mode can be recommended particularly for patients who reject any type of surgery, or mentally retarded patients in whom surgery is complicated as well as extended cases where an aggressive excision could cause the loss of limbar stem cells (Huerva, 2008) .
Topical INF or subconjunctival INF remains a controversial issue. A recent report concluded that subconjunctival 0.5 ml injection of 3 million IU IFN alfa 2b is a viable medical alternative for the treatment of ocular surface squamous neoplasia (OSSN) with a mean duration of follow-up of 55 months. The authors state that the advantages of perilesional INF alfa 2b injection include more rapid tumor resolution, ensured compliance, and perhaps more direct delivery to the tumor site when compared with topical INF drops. However, some patients may be apprehensive about receiving injections around the eye and may prefer eyedrops. A single weekly injection of INF may have better compliance than 4 eye-drops per day dosing for a mean of three months in many patients. Direct delivery to the tumor site may occur in well-localized lesions, while annular lesions or multifocal disease requires injection over the entire involved area, increasing the risk of conjunctival hemorrhage. By contrast, topical therapy is delivered to the entire ocular surface and has very good success rates. Topical therapy could be recommended for patients who reject any surgical procedure or those who are apprehensive about injections.
Weekly subconjunctival Pegilated INF alpha 2b might be an alternative in resistant cases of CIN or recurrent conjunctival papillomatosis avoiding a mutilating surgery (Tseng, 2009) , .
Other treatment possibilities
Other treatment options in the management of conjuctival OSSN include topical retinoids, cidofovir and photodynamic therapy (PDT). Topical unguent of trans-reinoic acid (0,01%) showed complete resolution of CIN in 20% of cases, whereas 40% showed only partial response (Espana el al, 2003 ). This treatment may be then only adjuvant to surgery Regression of diffuse conjunctival CIN was demonstrated following a 6 week course of topical cidofovir eyedrops (2.5 mg/ml) with later residual lesion after surgical excision (Sherman et al, 2002) .
Following PDT, using verteporfin, a complete clinical CIN regression, supported with angiographic evidence, has been reported at 1 month, without any recurrence for a mean follow-up of 8.6 months (Barbazetto et al, 2004) . Likewise, histopathological evidence showing tumor regression following treatment with PDT in a patient with in situ CIN has been reported (Sears et al, 2008) . The book "Intraepithelial neoplasia" is till date the most comprehensive book dedicated entirely to preinvasive lesions of the human body. Created and published with an aim of helping clinicians to not only diagnose but also understand the etiopathogenesis of the precursor lesions, the book also attempts to identify its molecular and genetic mechanisms. All of the chapters contain a considerable amount of new information, with an updated bibliographical list as well as the latest WHO classification of intraepithelial lesions that has been included wherever needed. The text has been updated according to the latest technical advances.This book can be described as concise, informative, logical and useful at all levels discussing thoroughly the invaluable role of molecular diagnostics and genetic mechanisms of the intraepithelial lesions. To make the materials easily digestive, the book is illustrated with colorful images.
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